サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375183

北米の臓器保存ソリューション市場の2028年までの予測-地域別分析-タイプ別、用途別、臓器タイプ別、エンドユーザー別

North America Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, Organ Type, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 146 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
北米の臓器保存ソリューション市場の2028年までの予測-地域別分析-タイプ別、用途別、臓器タイプ別、エンドユーザー別
出版日: 2023年08月28日
発行: The Insight Partners
ページ情報: 英文 146 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の臓器保存ソリューション市場は、2023年の1億2,036万米ドルから2028年には1億7,718万米ドルに成長すると予測されています。2023年から2028年までのCAGRは8.0%と推定されます。

腎不全につながる慢性疾患の増加が北米臓器保存ソリューション市場の成長を促進

腎臓移植は、世界的に最も一般的な臓器移植です。臓器調達・移植ネットワーク（OPTN）によると、2021年には米国で41,354件の臓器移植が実施され、2020年比で5.9％増加しました。腎臓移植は2万4,669件、肝臓移植は9,236件、心臓移植は3,817件でした。

慢性腎臓病（CKD）は、世界中で約10人に1人が罹患する、一般的で致命的な疾患です。さらに、全米腎臓財団が発表した研究によると、20歳以上の糖尿病人口が時間の経過とともに慢性腎臓病を発症すると予測しています。

全米腎臓財団は、2021年にはCKDが前立腺がんや乳がんよりも多くの人を死亡させると予測していると報告しています。慢性腎臓病は、広く認識されていない緊急疾患です。

米国疾病予防管理センター（CDC）が2020年に発表した推計によると、糖尿病の成人の3人に1人、高血圧の成人の5人に1人が慢性腎臓病に罹患している可能性があります。2021年に発表されたCDCの報告書によると、米国では毎年15％の人が慢性腎臓病を患っています。

全米腎臓財団は、腎臓障害を持つ人々は慢性腎臓病であることに気づいていないと述べており、これは腎臓病市場における潜在的な市場の可能性を示しています。これらの要因は、予測期間中の市場成長を促進すると予想されます。

北米の臓器保存ソリューション市場概要

北米の臓器保存ソリューション市場は、米国、カナダ、メキシコの主要3カ国に基づいて分析されます。米国は、臓器移植の増加や高齢者人口の増加などの要因により、臓器保存ソリューション市場で最大のシェアを占めています。

北米では、米国が臓器保存ソリューションの最大市場です。米国における慢性腎臓病の有病率の増加と高齢者人口の増加が、同市場の発展を加速させる可能性が高いです。例えば、National Chronic Kidney Diseaseのファクトシートによると、2021年には米国で慢性腎臓病患者は3,700万人に上る。さらに、米国腎臓基金（American Kidney Fund, Inc）によると、約81万人の米国人が腎不全を患っており、そのうち57万人の患者が透析を受けており、24万人が腎移植を受けています。また、CDCによると、慢性腎臓病（CKD）は、現在の推計値で45～64歳（12％）、18～44歳（6％）よりも65歳以上（38％）に多いです。さらに、米国ではCKDの有病率が増加しており、CKDに関連した健康問題は時間とともに悪化しています。また、CKDは心臓病や脳卒中の可能性を高める。このような事実から、腎臓移植の症例は今後数年間で増加する可能性が高いです。さらに、FDA認可の増加や、この地域における主要市場参入企業の存在が、市場の成長を後押ししています。例えば、2022年4月、TransMedics Group, Inc.は、循環死（DCD）後のドナーからの臓器に使用するOCS心臓システムの市販前米国食品医薬品局（FDA）承認を取得しました。

北米の臓器保存ソリューション市場の収益と2028年までの予測（金額）

北米の臓器保存ソリューション市場セグメンテーション

北米の臓器保存ソリューション市場は、タイプ、用途、臓器タイプ、エンドユーザー、国に区分されます。

タイプ別では、北米の臓器保存ソリューション市場はウィスコンシン大学ソリューション、カストディオールhtk、ペルファデックス、ハイポサーモゾール、その他に区分されます。2023年の北米臓器保存ソリューション市場シェアは、ウィスコンシン大学ソリューションセグメントが最大を記録しました。

用途に基づき、北米の臓器保存ソリューション市場は、静的低温保存、低体温マシン灌流、常温マシン灌流、その他に区分されます。2023年の北米臓器保存ソリューション市場シェアは、静的低温保存セグメントが最大でした。

臓器タイプに基づいて、北米の臓器保存ソリューション市場は腎臓、肝臓、肺、心臓、その他に区分されます。腎臓セグメントは2023年に北米の臓器保存ソリューション市場で最大のシェアを占めました。

エンドユーザー別では、北米の臓器保存ソリューション市場は臓器移植センター、病院、専門クリニックに区分されます。2023年の北米臓器保存ソリューション市場シェアは、臓器移植センター部門が最大でした。

国別に見ると、北米の臓器保存ソリューション市場は米国、カナダ、メキシコに分類されます。2023年には米国が北米の臓器保存ソリューション市場シェアを独占しました。

21ST CENTURY MEDICINE社、Accord Healthcare社、Bridge to Life Ltd社、Dr. Franz Koehler Chemie GmbH社、Lifeline Scientific社、OrganOx Limited社、Paragonix Technologies社、Preservation Solutions社、TransMedics社、Waters Medical Systems LLC社、XVIVO Perfusion社が、北米の臓器保存ソリューション市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 北米の臓器保存ソリューション市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の臓器保存ソリューション市場情勢

  • 概観
  • PEST分析
    • 北米-PEST分析
  • 専門家の見解

第5章 北米の臓器保存ソリューション市場-主要市場力学

  • 市場促進要因
    • 臓器移植ニーズの高まり
    • 腎不全につながる慢性疾患の有病率の増加
    • 高齢者人口の増加
  • 市場抑制要因
    • 高額な臓器移植手術
    • 臓器移植手術のドナー数の制限
  • 市場機会
    • 心血管疾患（CVDs）の有病率の上昇
  • 今後の動向
    • 新興国における成長機会
  • 影響分析

第6章 臓器保存ソリューション市場：北米分析

  • 北米の臓器保存ソリューション市場の収益予測と分析

第7章 北米の臓器保存ソリューション市場：収益と2028年までの予測：タイプ別

  • イントロダクション
  • ウィスコンシン大学ソリューション
  • カストジオールHTKs
  • パーファデックス
  • ハイポサーモゾール
  • その他

第8章 北米の臓器保存ソリューション市場：収益と2028年までの予測：用途別

  • イントロダクション
  • 北米の臓器保存ソリューション市場シェア：用途別、2022年および2028年（%）
  • 静的冷蔵保存
  • 低体温マシン灌流
  • 常温機械灌流
  • その他

第9章 北米の臓器保存ソリューション市場：収益と2028年までの予測：臓器タイプ別

  • イントロダクション
  • 北米の臓器保存ソリューション市場シェア：臓器タイプ別、2022年および2028年（%）
  • 心臓
  • 肺
  • 腎臓
  • 肝臓
  • その他

第10章 北米の臓器保存ソリューション市場：収益と2028年までの予測：エンドユーザー別

  • イントロダクション
  • 北米の臓器保存ソリューション市場シェア：エンドユーザー別、2022年および2028年（%）
  • 臓器移植センター
  • 病院
  • 専門クリニック

第11章 北米の臓器保存ソリューション市場：収益と2028年までの予測：国別分析

  • 北米：臓器保存ソリューション市場

第12章 北米の臓器保存ソリューション市場-業界情勢

  • イントロダクション
  • 臓器保存ソリューション市場の成長戦略
  • 無機的成長戦略
  • 概要
  • 有機的成長戦略
  • 概要

第13章 企業プロファイル

  • Waters Medical Systems LLC
  • XVIVO Perfusion
  • TransMedics
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • ST CENTURY MEDICINE
  • Bridge to Life Ltd
  • Preservation Solutions, Inc.
  • Lifeline Scientific, Inc.

第14章 付録

図表

List Of Tables

  • Table 1. United States Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 2. United States Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 3. United States Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 4. United States Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 5. Canada Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 6. Canada Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 7. Canada Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 8. Canada Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 9. Mexico Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 10. Mexico Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 11. Mexico Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 12. Mexico Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 13. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
  • Table 14. Recent Organic Growth Strategies in the Organ Preservation Solutions Market
  • Table 15. Glossary of Terms

List Of Figures

  • Figure 1. North America Organ Preservation Solution Market Segmentation
  • Figure 2. North America Organ Preservation Solution Market, by region
  • Figure 3. North America Organ Preservation Solution Market Overview
  • Figure 4. University of Wisconsin solution (UW) Segment Held Largest Share of Type Segment in North America Organ Preservation Solution Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America PEST Analysis
  • Figure 7. North America Organ Preservation Solutions Market Impact Analysis of Drivers and Restraints
  • Figure 8. North America Organ Preservation Solutions Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 9. North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
  • Figure 10. University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 11. Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 12. Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 13. Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 14. Others: North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 15. Medical devices market Share, by Application, 2022 and 2028 (%)
  • Figure 16. Static Cold Storage: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 17. Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 18. Normothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 19. Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 20. North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
  • Figure 21. Heart: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 22. Lung: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 23. Kidney: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 24. Liver: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 25. Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 26. North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
  • Figure 27. Organ Transplant Centers: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 28. Hospitals: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 29. Specialty Clinics: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 30. North America: Organ Preservation Solution Market, by Key Country - Revenue (2022) (US$ Thousand)
  • Figure 31. North America: Organ Preservation Solution Market, by Country, 2022 & 2028 (%)
  • Figure 32. United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 33. Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 34. Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 35. Growth Strategies in the Organ Preservation Solutions Market
目次
Product Code: TIPRE00025778

The North America organ preservation solutions market is expected to grow from US$ 120.36 Million in 2023 to US$ 177.18 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Increasing Prevalence of Chronic Diseases Leading to Kidney Failure Fueling North America Organ Preservation Solutions Market Growth

A kidney transplant is the most common organ transplant globally. According to the Organ Procurement and Transplantation Network (OPTN), in 2021, 41,354 organ transplants were performed in the US, an increase of 5.9% over 2020. There were a total of 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants.

Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately one in every ten people worldwide. Additionally, a study published by the National Kidney Foundation predicted that the diabetic population over the age of 20 would develop chronic kidney disease over time.

The National Kidney Foundation reported that CKD is expected to kill more people in 2021 than prostate or breast cancer. It is a widely under-recognized emergency health condition.

According to the estimates given by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. According to the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

The National Kidney Foundation states that people with kidney damage are unaware of having chronic kidney disease, which indicates the underlying market potential in the kidney disease market. These factors are expected to enhance market growth during the forecast period.

North America Organ Preservation Solutions Market Overview

The North America organ preservation solution market is analyzed based on three major countries: the US, Canada, and Mexico. The US holds the largest share of the organ preservation solution market owing to factors such as the increasing organ transplantation and growing geriatric population.

In North America, the US is the largest market for organ preservation solutions. Increasing prevalence of chronic kidney diseases and growing geriatric population in the US are likely to accelerate the development of this market. For instance, according to the National Chronic Kidney Disease fact sheet, in 2021, ~37 million people had chronic kidney diseases in the US. Furthermore, according to the American Kidney Fund, Inc, ~810,000 Americans have kidney failure, of which 570,000 patients are undergoing dialysis, and 240,000 have undergone kidney transplantation. In addition, according to the CDC, chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) with respect to the current estimate. Moreover, with the increasing prevalence of CKD in the US, CKD-related health problems worsen over time. It also increases the chances of having heart disease and stroke. Thus, owing to these facts, the cases of kidney transplantations are likely to increase in the coming years. Moreover, the rise in FDA approvals and the presence of the major market players in the region are boosting the market growth. For instance, in April 2022, TransMedics Group, Inc. received premarket U.S. Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD).

North America Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is segmented into type, application, organ type, end user, and country.

Based on type, the North America organ preservation solution market is segmented into University of Wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The University of Wisconsin solution segment registered the largest North America organ preservation solution market share in 2023.

Based on application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest North America organ preservation solution market share in 2023.

Based on organ type, the North America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest North America organ preservation solution market share in 2023.

Based on end user, the North America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest North America organ preservation solution market share in 2023.

Based on country, the North America organ preservation solutions market has been categorized into the US, Canada, and Mexico. The US dominated the North America organ preservation solutions market share in 2023.

21ST CENTURY MEDICINE; Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are the leading companies operating in the North America organ preservation solutions market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America organ preservation solution market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Organ Preservation Solution Market - by Type
    • 1.3.2 North America Organ Preservation Solution Market - by Application
    • 1.3.3 North America Organ Preservation Solution Market - by Organ Type
    • 1.3.4 North America Organ Preservation Solution Market - by End User
    • 1.3.5 North America Organ Preservation Solution Market - by Country

2. North America Organ Preservation Solution Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Organ Preservation Solution Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
  • 4.3 Expert Opinions

5. North America Organ Preservation Solution Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Need for Organ Transplantation
    • 5.1.2 Increasing Prevalence of Chronic Diseases Leading to Kidney Failure
    • 5.1.3 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Expensive Organ Transplant Surgeries
    • 5.2.2 Limited Number of Donors for Organ Transplant Surgeries
  • 5.3 Market Opportunities
    • 5.3.1 Rising Prevalence of Cardiovascular Diseases (CVDs)
  • 5.4 Future Trends
    • 5.4.1 Growth Opportunities in Emerging Nations
  • 5.5 Impact Analysis

6. Organ Preservation Solution Market - North America Analysis

  • 6.1 North America Organ Preservation Solutions Market Revenue Forecast and Analysis

7. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
    • 7.1.1 North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
  • 7.2 University of Wisconsin Solution (UW) Market
    • 7.2.1 Overview
    • 7.2.2 University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.3 Custodiol HTKs
    • 7.3.1 Overview
    • 7.3.2 Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.4 Perfadex
    • 7.4.1 Overview
    • 7.4.2 Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.5 Hypothermosol
    • 7.5.1 Overview
    • 7.5.2 Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)

8. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Application

  • 8.1 Overview
  • 8.2 North America Organ Preservation Solutions Market Share, by Application, 2022 and 2028 (%)
  • 8.3 Static Cold Storage
    • 8.3.1 Overview
    • 8.3.2 Static Cold Storage: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.4 Hypothermic Machine Perfusion
    • 8.4.1 Overview
    • 8.4.2 Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.5 Normothermic Machine Perfusion
    • 8.5.1 Overview
    • 8.5.2 Normothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)

9. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Organ Type

  • 9.1 Overview
  • 9.2 North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
  • 9.3 Heart
    • 9.3.1 Overview
    • 9.3.2 Heart: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.4 Lung
    • 9.4.1 Overview
    • 9.4.2 Lung: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.5 Kidney
    • 9.5.1 Overview
    • 9.5.2 Kidney: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.6 Liver
    • 9.6.1 Overview
    • 9.6.2 Liver: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)

10. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by End User

  • 10.1 Overview
  • 10.2 North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
  • 10.3 Organ Transplant Centres
    • 10.3.1 Overview
    • 10.3.2 Organ Transplant Centres : North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 10.4 Hospitals
    • 10.4.1 Overview
    • 10.4.2 Hospitals: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 10.5 Specialty Clinics
    • 10.5.1 Overview
    • 10.5.2 Specialty Clinics: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)

11. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 -Country Analysis

  • 11.1 North America: Organ Preservation Solution Market
    • 11.1.1 Overview
      • 11.1.1.1 United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.1.3 United States: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.1.4 United States: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.1.5 United States: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.1.6 United States: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)
      • 11.1.1.2 Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.2.3 Canada: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.2.4 Canada: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.2.5 Canada: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.2.6 Canada: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)
      • 11.1.1.3 Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.3.3 Mexico: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.3.4 Mexico: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.3.5 Mexico: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.3.6 Mexico: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)

12. North America Organ Preservation Solution Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Organ Preservation Solutions Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Waters Medical Systems LLC
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 XVIVO Perfusion
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 TransMedics
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 OrganOx Limited
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Paragonix Technologies, Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Dr. Franz Koehler Chemie GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Accord Healthcare
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8ST CENTURY MEDICINE
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Bridge to Life Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Preservation Solutions, Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Lifeline Scientific, Inc.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms